Remco van Doorn
0000-0002-7019-6673
197 papers found
Refreshing results…
Gene-expression profiling and array-based CGH classify CD4 +CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities
Gene-expression profiling and array-based CGH classify CD4(+)CD56(+) hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities
Integrated genomic analysis classify CD4+CD56+hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities and reveal novel diagnostic and therapeutic targets
Aberrant DNA Methylation in Cutaneous Malignancies
Aberrant DNA methylation in cutaneous malignancies.
Epigenetic Profiling of Cutaneous T-Cell Lymphoma: Promoter Hypermethylation of Multiple Tumor Suppressor Genes Including BCL7a, PTPRG, and p73
Intravascular large B-cell lymphoma,Intravasculair grootcellig B-cel lymfoom
Aberrant DNA methylation in cutaneous malignancies
Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis
Genetic and clinical mosaicism in a patient with neurofibromatosis type 1
Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor
Follicular Mycosis Fungoides, a Distinct Disease Entity With or Without Associated Follicular Mucinosis
Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: A clinicopathologic and follow-up study of 51 patients
CD8+ T Cells in Cutaneous T-Cell Lymphoma: Expression of Cytotoxic Proteins, Fas Ligand, and Killing Inhibitory Receptors and Their Relationship With Clinical Behavior
Mycosis Fungoides
Skin equivalent: an attractive model to evaluate early melanoma metastasis:
Mycosis fungoides: Disease evolution and prognosis of 309 Dutch patients
Missing publications? Search for publications with a matching author name.